This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Raspberry Lift Healthy Body Fruit Notes feature a balanced blend of cannabinoids designed to increase mental clarity and encourage positive eating habits.
InMed Pharmaceuticals Inc. has launched B2B sales of delta-9-dominant tetrahydrocannabivarin (THCV) into the health and wellness sector via its wholly-owned subsidiary, BayMedica LLC.
In the first half of 2022, Radicle Science will continue to conduct rigorous clinical trials on CBD products while also commencing on blinded, randomized, placebo-controlled clinical trials on rare cannabinoids.
Keef Brands has unveiled purpose-driven beverages with minor cannabinoids designed to offer functional effects, including stimulation, relaxation, and sleep.
CannaCraft has launched its new brand Gem + Jane, a women-focused sparkling botanical beverage that blends simple ingredients with microdoses of cannabinoids.
Cannabis Global, Inc. says it has successfully applied production techniques developed for tetrahydrocannabivarin (THC-V) to cannabinol (CBN), another rare cannabinoid the company believes has growth potential as a new cannabinoid-based products market.
Pending full release of the products, the company has implemented a 30-day beta testing period, during which production for general release will continue.